ONCO: SEC Form 8-K filed by Onconetix Inc.
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for ONCO
Across the 17 sessions after earlier ONCO headlines, the stock closed higher 5 times and lower 12 times, with a median move of 7.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ONCO | SPY |
|---|---|---|---|
| Oct 23, 2026 | Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition | +2.8% | -0.5% |
| Sep 14, 2026 | CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition | -15.7% | -0.4% |
| Sep 3, 2026 | Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events | +9.6% | +1.0% |
| Aug 12, 2026 | Realbotix Reports Financial Results for Q3-2026 | -7.9% | +0.3% |
| Aug 6, 2026 | Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series | -10.1% | -0.2% |
| Aug 5, 2026 | Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG | +20.4% | -0.2% |
Quantisnow market dataNASDAQ
ONCO
Onconetix Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2022
Get push alerts for ONCO
Full ONCO profile on Quantisnow Follow ONCO and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time